학술논문

694P Full efficacy analysis of phase I/II trial investigating bexmarilimab, a novel macrophage-guided immunotherapy in refractory solid tumors
Document Type
Abstract
Source
In Annals of Oncology October 2023 34 Supplement 2:S483-S484
Subject
Language
ISSN
0923-7534